Luciferase reporter constructs are widely used for analysis of gene regulation when characterizing promoter and enhancer elements. We report that the recently developed codon-modified Renilla luciferase construct included as an internal standard for cotransfection must be used with great caution with respect to the amount of DNA transfected. Also, the dual-luciferase reporter vectors encoding Photinus pyralis firefly or Renilla reniformis luciferase showed a linear increase in dose-response with increasing amounts of transfected DNA, but at higher levels of transfected DNA, a reduction in expressed levels of luciferase activity resulted. In addition, treatment with type I interferon (IFN) was found to significantly reduce levels of P. pyralis firefly and Renilla luciferase activity. In contrast, cells transfected with a green fluorescent protein (GFP) reporter construct showed no significant IFN-associated change. The reduction in luciferase activity resulting from IFN treatment was not due to IFN-mediated cytotoxicity, as no change in cellular propidium iodide (PI) staining was observed by flow cytometry. IFN treatment did not alter the levels of firefly luciferase activity in cell culture supernatants or the luciferase mRNA levels determined by quantitative real-time RT-PCR analysis. Based on these results, it is probable that the IFN-induced reduction in levels of luciferase activity detected in reporter assays occurs via a posttranscriptional mechanism. Thus, it is important to be aware of these complications when using luciferase reporter systems in general or for analyzing cytokine-mediated responsive regulation of target genes, particularly by the type I IFNs.
INTRODUCTION R
EPORTER GENE ASSAYS ARE ROUTINELY USED in studies whose aim is the functional characterization of putative promoter or enhancer regions. Three popular reporter proteins used for this purpose include green fluorescent protein (GFP), Photinus pyralis firefly luciferase, and Renilla reniformis luciferase. The latter two assays represent the most widely used reporter enzymes available for transcriptional regulation studies. GFP is used for investigating the localization dynamics and characteristics of gene expression. GFP assays are simple and allow monitoring of kinetics of GFP and GFP-tagged molecules within living cells. By comparison, luminescence assays with transiently expressed firefly luciferase provide for convenient and sensitive linear readout for accurate quantification over a wide range of enzyme concentrations. R. reniformis luciferase is commonly used as a control for transfection efficiency and is often included with firefly luciferase in gene reporter assays.
Reporter constructs are generally used with the assumption that the activity of the encoded reporter proteins is not directly affected by the agents tested or the treatment conditions. As a result, the effects that various test treatments and parameters might have in altering the reporter output are rarely considered. Recent reports, however, have described some complications resulting from the effect of biologically active compounds on the activity of certain reporter constructs. For example, Kogai et al. (1) demonstrated that retinoic acids induce increased expression of the modified firefly luciferase reporter gene (lucϩ) from the pGL3-basic vector (Promega Corp., Madison, WI). This is despite the claims of the manufacturer that suggest that because the pGL3-basic construct contains a minimal promoter region, it should be suitable as a control in transfection-based gene regulation studies. In addition, an effect of androgen on the Renilla luciferase reporter expression has been described when assayed in the context of the herpes simplex virus (HSV)-thymidine kinase promoter. (2) Both studies describe the cautionary requirements imposed by such technical difficulties in interpreting gene regulatory data.
Interferons (IFNs), which include type I IFNs (IFN-␣ and IFN-␤) and type II IFN (IFN-␥), are widely studied multifunctional cytokines with considerable biomedical significance. The ability of type I IFNs to inhibit cell proliferation and to produce cytotoxic effects on cancer cells has resulted in their use as anticancer therapies (reviewed in refs. 3, 4) . In addition, IFNs can induce apoptosis in tumor cells, making them important therapeutics for clinical use in treating cancers. (5, 6) IFNs are also potent antiviral agents, resulting in their application in the therapy of viral hepatitis. (7) (8) (9) (10) The multifunctional effects of IFNs on cells are mediated via intracellular signaling pathways, activation of which regulates expression of IFN-stimulated genes (ISGs). (11, 12) Several studies have reported that IFNs can also affect gene expression at the posttranscriptional level (reviewed in refs. 13, 14) . For instance, it has been demonstrated that IFN-␤ treatment causes inhibition of cellular protein synthesis. (15) We have investigated the effect of IFN treatment on the commonly used reporter genes, GFP, P. pyralis firefly luciferase, and Renilla luciferase. Here we report that (1) type I IFN inhibits the levels of expressed activity produced from both the firefly and Renilla luciferase reporter vectors in transient transfection reporter assays, (2) the repression in levels of luciferase activity by type I IFN is likely to be mediated through a posttranscriptional mechanism, (3) the recently developed codon-modified Renilla luciferase construct (Promega Corp.), when included as an internal standard for cotransfection, must be used with great caution with respect to the amount of DNA transfected, and (4) both of the dual-luciferase reporter vectors show a linear range in dose-response with increasing amounts of transfected DNA but, if used in excess, will cause inhibition in expressed levels of luciferase activity. Our observations are particularly relevant to the ready use of commercially available systems, such as the Dual-Glo reporter assay (Promega Corp.), as these are gaining in popularity because of their simplicity and ease of application.
MATERIALS AND METHODS

Cell culture and treatment
The human melanoma cell line SK-MEL-28 (American Type Culture Collection [ATCC] Rockville, MD) was grown in RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS). The human cervical adenocarcinoma cell line HeLa S3 (ATCC) was grown in DMEM supplemented with 10% FBS. Cells either were left without stimulation or were treated with 1000 IU/ml IFN-␣, IFN-␤, or IFN-␥, unless otherwise indicated.
Construction of reporter plasmids
The pGL3-basic luciferase reporter vector containing lucϩ, a modified form of the gene encoding firefly (P. pyralis) luciferase, was used to prepare the ISG15-luc construct as a positive control for type I IFN stimulation. The oligonucleotide design as described in Wong et al., (16) which was based on the canonical ISG15 IFN-stimulated response element (ISRE) site was modified at the overhangs to enable use of the restriction enzymes, KpnI and BglII, compatible for insertion into the pGL3 vector. Complementary oligonucleotides were annealed at equal molar ratios and cloned into the pGL3-basic vector (5Ј-CATGCCTCGGGAAAGGGAAACCGAAACTGAAGCC-3Ј and antisense 5Ј-GATCGGCTTCAGTTTCGGTTTCCCTT-TCCCGAGGCATGGTAC-3Ј). The underlined sequence contains the ISRE from the ISG15 gene promoter and was used to regulate firefly luciferase in ISG15-luc. The pEF-luc (17) construct contained the lucϩ gene derived from the pGL3-basic vector and then cloned into the pEFMCIneopAN9 (16, 17) vector via KpnI and XbaI restriction enzyme sites downstream from the EF-1␣ promoter. The phRL-SV40 vector (Promega Corp.) contains a modified luciferase gene derived from R. reniformis. The pBOS-H3-N-GFP expression vector encoding H3 histone tagged with GFP was a kind gift from Dr J. Neuzil (School of Health Science, Griffith University). This vector contains the histone H3-GFP gene with a 23-residue linker under the control of the EF-1␣ promoter. (18) 
Cell transfection
Transfection complexes were formed using a ratio of 1 g vector DNA (pGL3-basic, ISG15-luc, pEF-luc, phRL-SV40, or pBOS-H3-N-GFP plasmid) to 1 l Lipofectamine 2000 (Invitrogen Corp., San Diego, CA) or Fugene 6 (Roche Applied Science, Nutley, NJ) for 20-40 min. Then, 50 l DNA/transfection reagent mix was added to 50 l serum-free Opti-MEM I medium (Invitrogen Corp.) using a procedure based on the manufacturer's instructions, without the presence of antibiotics. SK-MEL-28 and HeLa S3 cells were cultured for 24 h prior to transfection at a density of 7.5 ϫ 10 3 and 1.5 ϫ 10 4 cells, respectively, per well, in a 96-well tissue culture plate with 150-200 l complete medium/well. Culture medium was replaced by the addition of the 100 l transfection complex. At 3-4 h after transfection, the medium was replaced with ϳ200 l fresh complete medium. At 20-24 h posttransfection, cells either were left untreated or were stimulated with 1000 IU/ml IFN-␤ (Biogen, Cambridge, MA) IFN-␣2b, or IFN-␥ (Hoffman-La Roche, Basel, Switzerland), unless otherwise indicated, and incubated for a further 16 h.
For the dose-response, time course, and flow cytometry experiments, SK-MEL-28 cells were first seeded in 10-cm dishes at approximately 80% confluency and were transfected with 12 g plasmid DNA using 24 l Lipofectamine 2000 (50% w/v). At 18 h posttransfection, cells were subcultured into 24 ϫ 2 ml/well plates at approximately 40% confluence per well, and after a further 6 h (24 h posttransfection), they were treated with IFN.
Assay of luciferase activity
Following IFN stimulation and at the times indicated, cell lysates or supernatants or both were prepared and assayed for luciferase activity. Cells in wells of a 24-well plate were detached by incubation in 30 l 90 M EDTA/phosphate-buffered saline (PBS) (37°C, 5 min) and were then lysed at ambient tem-perature by the addition of 70 l lysis buffer (37.5 mM Trisphosphate, pH 8, 15% glycerol, 1.5% Triton-X-100, 1.5 g/l bovine serum albumin [BSA] , and 3 mM DTT). For measurement of luciferase activity, a modified procedure based on the Dual-Glo luciferase reporter assay protocol was used. Thus, for the firefly luciferase assay, 100 l of reaction buffer was added to the cell lysates in each well. The reaction buffer contained 40 mM Tricine, pH 8.0, 16 mM magnesium chloride, 0.26 mM EDTA, pH 8.0, and 60 mM DTT, as well as 0.6 mM coenzyme A (CoA), 1 mM beetle luciferin and 1 mM ATP, which were added to the reaction buffer immediately before use and just before measurement of luciferase activity. For the time course and relative titration experiments, cells were lysed in 50-100 l PBS in situ in the wells of the 96-well or 24-well microtiter culture dishes by two successive freeze (Ϫ80°C)-thaw cycles.
For those titration experiments where the effects of phRL-SV40 Renilla reporter plasmid on firefly luciferase were examined, the first reaction buffer (for firefly luciferase measurements) comprised 40 mM Tricine, pH 8.0, 16 mM magnesium chloride, 260 M EDTA, pH 8.0, and 60 mM DTT, as well as 0.6 mM CoA, 1 mM beetle luciferin, 1 mM ATP, 15% glycerol, 0.1% Tergitol-NP9, and 1.5 g/l BSA. For the second reaction buffer (for Renilla luciferase measurements), the following components were prepared as a 3 ϫ concentrated Stop-Glow stock solution: 22.5 mM sodium pyrophosphate, 22.5 mM sodium acetate, pH 5.9, 30 mM CDTA, 600 mM sodium sulfate, 9 mM thiourea, 0.01% Tween-20, and 1 M coelenterazine (Promega). This was diluted one third by the addition to the first reaction volume containing firefly luciferase. Luciferase activity was measured in a luminometer (FLUOstar OPTIMA, BMG Labtechnologies, Melbourne, Australia). Replicates (3-4 wells) were used for each sample, and each experiment was repeated at least twice.
Propidium iodide (PI) staining and fluorometric assays
pBOS-H3-N-GFP transfectants were harvested 16 h after IFN stimulation. Cells were resuspended at 3 ϫ 10 4 cells/0.45 ml PBS buffer containing 1% FBS and were stained with PI at a final concentration of 5 g/ml within 15 min prior to sample analysis. The green (454 nm) fluorescence and PI fluorescence of cells were measured by fluorescence cytometry using a FACScalibur (Becton Dickinson, Sydney, Australia).
RNA preparation and quantitative RT-PCR analysis
Total RNA was extracted from 8.8 ϫ 10 4 cells after 12 h of IFN treatment and isolated using NucleoSpin RNA II minispin columns (Machery-Nagel, Düren, Germany). For cDNA synthesis, random decamers and the MMLV RNase H Ϫ reverse transcriptase (RT) (Promega Corp.) were used (42°C, 45 min) in a final 20-l reaction volume. Amplification of specific targets from 2 l of a 1:5 dilution of the cDNA pool was carried out using the SYBR Green I iQ SUPERMIX (Bio-Rad Laboratories, Hercules, CA). PCR product in real-time was detected using the IQ iCycler System (Bio-Rad Laboratories). Specific primers used were: Lucϩ forward, 5Ј-CATCTTCGAC-GCAGGTGTC-3Ј; reverse, 5Ј-GACTGGCGACGTAATCCA-C-3Ј; ISG15 forward, 5Ј-GTGCAGGACGACCTGTTCT-3Ј; reverse, 5Ј-GATTCATGAACACGGTGCTC-3Ј; ISG54 forward, 5Ј-TGCAACCTACGGCCTATCTA-3Ј; reverse, 5Ј-CA-GGTGACCACACTTCTGATT-3Ј; 18SrRNA forward, 5Ј-CT-TAGAGGGACAAGTGGCG-3Ј; reverse, 5Ј-ACGCTGAGC-CAGTCAGTGTA-3Ј. The specific annealing for Lucϩ, 18Sr-RNA, and ISG15 primers was determined to be 59°C. For the ISG54 primer, this was set at 61°C. Cycling conditions were 95°C for 2 min, 95°C for 30 sec, 59°C/61°C for 1 min, 72°C for 30 sec ϫ 45. The specificity of PCR product obtained at end point was confirmed by melt curve analysis and 10% PAGE in 1 ϫ TBE.
Data analysis and statistics
Statistical analysis was performed using version 12 SPSS software (SPSS Inc., Chicago, IL). Data are reported as means Ϯ SE. Independent t-test or ANOVA (more than two groups) was used to determine the significance of the differences between the means (p Ͻ 0.05). Methods for analysis of Q-PCR data have been described previously. (19, 20) Comparative values for cycle threshold at linearity (C t ) were obtained relative to the reference 18SrRNA (⌬C t (21) ). The fold difference (2 Ϫ⌬⌬CT ) between treated and untreated cells was determined to be significant if the ⌬C t values for test and ⌬C t values for control were statistically significantly different.
RESULTS
IFN-␣/␤ treatment of cells transfected with luciferase reporter constructs causes reduced expression of luciferase activity
The IFN-sensitive SK-MEL-28 and HeLa S3 cells were transiently transfected with the high expression reporter vector, pEF-Luc, to determine if IFN treatment affected the resulting activity levels of firefly luciferase (P. pyralis) produced in cell transfectants. The results (Fig. 1A ,B) revealed that after 16 h of IFN treatment, a significant reduction (ϳ30%-60%) in luciferase activity was observed in both cell lines in response to 1000 IU/ml of either IFN-␣ or IFN-␤, whereas the same concentration of IFN-␥ (1000 IU/ml) showed no effect. With the SK-MEL-28 cells, the extent of inhibition caused by IFN-␤ treatment was more substantial (ϳ60%) than that resulting from IFN-␣ treatment (ϳ30%).
Next, dose-response curves with type I IFN treatment were analyzed over a range of IFN-␤ concentrations for their effect (Fig. 1C) . The results revealed that increasing amounts of IFN-␤ from 25-1600 IU/ml were increasingly effective at reducing the luciferase activity detected in the cell transfectants. Amounts as low as 25 IU/ml IFN-␤ were sufficient to produce a reduction of ϳ20% in luciferase activity compared with the levels obtained in control transfected cells. Given the extent of repression in levels of luciferase activity obtained with the higher IFN concentrations, a concentration of 500 IU/ml IFN-␤ was selected for subsequent experiments.
The results of a time course of IFN treatment of transfectants over several days (Fig. 1D) showed no significant reduction in luciferase activity between the IFN-␤-treated and untreated cells occurring within the initial 8 h after addition of IFN. However, a more rapid reduction (over 30% below control) in levels of firefly luciferase activity occurred by 16-24 h in the IFN-treated population, followed by a steady decline in parallel with the rate of decay occurring in the control cells. Studies were not carried out beyond 72 h because luciferase activity was continuing to decline at a similar steady rate in both treatment and control groups at this time (Fig. 1D) .
Type I IFN also reduced R. reniformis luciferase activity expressed in transfectants. To investigate the influence of IFN treatment on Renilla luciferase expression, SK-MEL-28 cells were transiently transfected with the codon-modified Renilla luciferase reporter vector, phRL-SV40, where the luciferase gene is controlled by the SV40 large T promoter. As with the pEF-luc firefly luciferase transfectants (Fig. 2) , 16 h of IFN treatment caused significant inhibition in luciferase activity in response to 1000 IU/ml of either IFN-␣ or IFN-␤, whereas no significant effect of 1000 IU/ml IFN-␥ was noted. The magnitudes of the reduction in Renilla luciferase activity caused by IFN-␤ or IFN-␣ were not as marked as for pEF-luc but were about 18%-20%.
To test whether the type I IFN-mediated inhibition of expressed luciferase activity would be compensated by normalizing the data against the values obtained from the Renilla luciferase in a dual-luciferase reporter cotransfection assay (data not shown), the percentages of IFN-mediated reduction in firefly and Renilla luciferase activities were calculated and compared with the untreated controls. IFN-␤ treatment caused an approximately 40% reduction in firefly luciferase activity and a 19% reduction in Renilla luciferase activity. IFN-␣ treatment led to an approximately 30% reduction in firefly luciferase activity and an 18% reduction in Renilla luciferase activity. Based on this analysis, the percentage reduction in Renilla luciferase activity was lower than that observed for firefly luciferase. Hence, data normalization with this control would have only partially compensated for the differential influence of IFN treatment on these reporter activities and would, therefore, have led to the results being compromised.
Initial IFN-induced reduction of luciferase reporter gene activity in transfected cells did not result from cytotoxic effects of IFN on these cells
It was possible that the initial effect of type I IFN in reducing the levels of firefly luciferase activity might have resulted from IFN-induced death of the transfectants. Hence, cytotoxicity assays were undertaken to analyze the effects of IFN treatment of cells over this period. Initial studies to assess this possibility were carried out by monitoring the luciferase activity present in culture supernatants after transiently transfecting the pEF-luc vector into SK-MEL-28 cells and treating the transfectants with IFN-␤. Assays based on the release of reporter enzymes have been used previously to provide an indication of membrane perforation and cell death initiated either by cellmediated cytotoxicity or by complement-mediated killing. (22) IFN-␤ treatment did not cause increased release of luciferase activity. On the contrary, the luciferase activity assayed in culture supernatants of untreated cells was significantly greater at 24-48 h post-IFN treatment compared with that of the IFN-␤-treated cells (Fig. 3) . In fact, the levels of luciferase activity detected in the supernatants were directly proportional to the levels detected in the cells (results not shown). Hence, the results indicated that the changes in luciferase expression mediated by IFN-␤ were not caused by any cytotoxic effect compromising cell membrane permeability.
Reduction in luciferase reporter gene expression in transfected cells treated with IFN is not the result of IFN affecting the level of reporter gene transcription
To determine if the IFN-mediated inhibition of firefly luciferase activity was the result of an effect of IFN on transcription, causing reduced levels of luciferase mRNA expression, Q-PCR analysis was conducted. IFN-␤-inducible activity was confirmed with cells transfected using the type I IFN-inducible ISG15-luc vector construct (Fig. 4A,B) . Next, total RNA was isolated from SK-MEL-28 cells that had been transiently transfected with pEF-Luc and either maintained in culture or treated with 500 IU/ml IFN-␤ for 12 h. C t values were obtained and normalized using 18S rRNA as reference. After comparison with controls, the activity of IFN on the cells was validated by the large fold increase detected in endogenous ISG15 and ISG54 gene expression (Fig. 4D) . However, no significant difference was detected in the ⌬C t values for pEF-luc expression levels between the transfectants treated or not with IFN (Fig.  4D) . Thus, IFN-␤ did not significantly affect luciferase mRNA levels at the 12 h time point after treatment, indicating that the IFN-␤-mediated reduction in luciferase levels of activity was unlikely to be the result of transcriptional regulation of the luciferase genes. luc vector used to examine the effects of type I IFNs on firefly luciferase expression. For the GFP experiments, transfected cells either were left untreated or were stimulated with 500 IU/ml IFN-␤ or 1000 IU/ml IFN-␥. Conditions of transfection were optimized for this experiment by using HeLa S3 cells as targets and visually counting the percentage of cells expressing GFP. The results from fluorescence cytometric analysis of GFP fluorescence activity at 16 h after IFN treatment indicated no significant differences in the mean levels (in fluorescence intensities) between the populations of IFN-stimulated vs. untreated control cells (results not shown).
A second set of experiments aimed at determining whether the type I IFN mediated reduction in pEF-luc firefly luciferase resulted from induced cell death or other cytotoxic effect was carried out. In this case, PI uptake into transfectants was analyzed. PI is an early indicator of compromised cell viability, in which case it stains the intracellular nucleic acids and can be sensitively detected by flow cytometry. (24, 25) No significant difference was observed in the percentage of PI-positive cells assessed after 16 h of IFN-␤ or IFN-␥ treatment (results not shown). In addition, no significant difference was detected in either forward or side scatter profiles of the same cell samples analyzed by flow cytometry (results not shown). Changes in these latter two measurements are also indicators of cellular apoptosis (as decreased cell size and increased cell granularity, respectively. (24, 25) Thus, our results indicated that type I IFN treatment did not significantly affect the cell viability over the 16 h time period.
Titration of luciferase reporter vectors revealed inhibitory effects occurring at high levels
As many transfection and reporter assays typically use between 1 and 2 g of luciferase reporter DNA, this amount was initially tested in our cotransfection assays to examine gene activity with respect to the reference reporter included as control (phRL-SV40, encoding a modified Renilla luciferase). However, it rapidly became apparent that the use of the modified Renilla vector at these levels caused severe inhibitory effects when cotransfected with different firefly luciferase reporter constructs. To examine this further, titration studies were performed whereby fixed amounts of either of two different firefly luciferase constructs (ISG15-luc or pEF-luc) were cotransfected with increasing amounts of the Renilla vector DNA. The results with the 96-well microtiter or 24 ϫ 2 ml-well plate formats for cell transfection used in this study showed that the inhibitory effect with increasing amounts of the Renilla vector became quite marked with DNA levels above ϳ40-100 ng (Fig.  5) . For these studies, the IFN-inducible constructs ISG15-luc vector or pEF-luc vector was transfected into SK-MEL-28 cells. The ISG15-luc transfected cells were also treated (or not) with IFN to examine the effect of increasing concentrations of DNA on the levels of inducible expression. The signals from both ISG15-luc and pEF-luc were then examined with respect to introducing increasing amounts of the control/reference vector, Renilla phRL-SV40, which was also cotransfected into the cells. The results with the ISG15 reporter (Fig. 5A) revealed that increasing amounts of Renilla vector over the range 1 to 100 ng in the 24 ϫ 2 ml/well plate format produced increased output of Renilla luciferase signal without affecting the firefly luciferase activity levels. However, further increases in levels of Renilla vector above 100 ng caused an inhibitory effect, severely reducing the output signals from the ISG15-luc firefly and Renilla luciferase reporters regardless of whether or not cells were treated with IFN (Fig. 5A) .
Similar, albeit not as marked, inhibition also resulted when the pEF-luc firefly luciferase construct (Fig. 5B) was tested in the 96-well microtiter plate format. In this titration experiment, the output from the Renilla luciferase vector increased over the range 1-40 ng of cotransfected Renilla DNA. However, the outputs from either cotransfected pEF-luc firefly luciferase or Renilla luciferase were reduced when the levels of Renilla vector DNA used for transfection went above 40 ng. Thus, cotransfecting Renilla and firefly luciferase vectors at too high a level of input DNA can impede the resulting level of enzyme activity expressed from both vectors in dual reporter assays, independent of the nature of the promoter regulating the luciferase genes.
Inclusion of pGL3-basic vector DNA as carrier in cotransfection luciferase reporter assays does not prevent inhibition resulting from use of excessive levels of reporter vector DNA
To determine if the reduction in reporter activity detected with increasing amounts of transfected DNA was caused by changes in the ratio of transfection reagent to total DNA (Fig.  5) , further studies were carried out. Thus, titration assays with the cotransfected reporters were performed in 96-well microtiter plates whereby constant amounts of total DNA were maintained (ϳ400 ng) using the pGL3-basic vector DNA as a carrier. For the experiment, the level of Renilla was fixed at 4 ng, and pEFluc was titrated over a range of 2.5 to 400 ng. The results (Fig.  6 ) of this experiment revealed that the use of a carrier to standardize the amount of total DNA transfected helped overcome variability in the assay. This can be seen by the 40%-50% reduction in error in the data recorded when comparing the respective slopes of the graphs in Figure 5B with those in Figure  6 . Furthermore, the results in Figure 6 revealed a direct linear relationship between increased luciferase activity expressed and increased input amount of DNA, up to ϳ200 ng in this case for the test vector, pEF-luc. When amounts of pEF-luc vector exceeded 200 ng, however, the levels of luciferase activity expressed from both the Renilla control and the pEF-luc reporter vector were reduced (Fig. 6) . Thus, it is important to closely monitor the DNA dose-response relationship when using these gene reporter vectors to ensure that the amount transfected into cells is within the linear range, or erroneous results will be obtained.
DISCUSSION
With their commercial availability and convenience, use of dual-luciferase reporter enzyme systems is becoming widespread, and they are increasingly used in studies of gene regulation in mammalian cells. The results reported here suggest that the activities of the modified firefly and Renilla luciferase are both inhibited by IFN-␣/␤ (type I IFNs) treatment in reporter assays ( Fig. 1 and 2 ). This finding has significant implications for the interpretation of data in studies using these reporter assay systems. Analysis of expression from a transfected vector expressing encoded histone H3-GFP by fluorescent activity over similar time periods indicated no significant differences in the levels of expression between IFN-treated and untreated cells (results not shown). Thus, histone H3-GFP gene expression as measured by fluorescence levels is not sensitive to type I IFN in the same manner as observed for the luciferases. This result would indicate that GFP-based reporter vectors might be the preferred method for the study of IFN-responsive genes and their regulation. However, it has been found that the sensitivity of reporter assays involving GFP are limited by the long-term stability of GFP (26) and other problems associated with high levels of background autofluorescence exhibited by cells at the same emission wavelength as that of GFP. (27) The value of luciferase reporter constructs is that they generate strong signals and have a large dynamic range, able to detect very low to very high levels of induced expression above background. The results of this study suggest that data collected after luciferase reporter construct transfection assays should be considered within the context of the effects of the biologic test agent or cytokine used. Several luciferase constructs should be employed, and consistent results and induction in response to the test agent should be used as the basis for further study. Based on our data, it is recommended that for a 96-well plate format, one should maintain the levels of Renilla plasmid at 2-5 ng, as this provides sufficient signal of Renilla luciferase as a reference reporter while clearly remaining below the level of luciferase inhibition (Fig. 5B) . For reporter test plasmids, the optimal level should be that which lies on the linear part of the curve (Յ200 ng) (Fig. 6) . When transfecting cells in formats other than 96-well plates, it is recommended to increase the amount of plasmid reporter DNA in proportion to the target cell number.
The inhibitory effect of type I IFN detected in the present study with the firefly luciferase reporter would not have been compensated by the use of the R. reniformis luciferase control vector because the two vectors were affected to a different extent. As a result, standardizing the data in this manner would have produced inaccurate or misleading results when attempting to study gene regulatory elements. This situation would become even more important when studying a promoter that is only weakly responsive to type I IFNs. Clearly, continued use of luciferase in such situations as the ISG15 promoter (Fig.  4A,B) is appropriate where the effects of IFN are large and induction above background is readily discerned. Where IFN induction is small, it may be possible to reduce the incubation times with IFN-␣/␤ to 8 h, as no significant type I IFN-associated luciferase inhibition was observed at this time in the time course experiment of IFN treatment (Fig. 1D) .
The type I IFN-induced reduction in luciferase activity was not the result of cytotoxic effects of IFN. It is known that IFN treatment can cause upregulation of genes involved in stress response and apoptosis. (28) However, our results revealed no significant difference in the percentage of PI staining at 16 h detected in the IFN-treated vs. control SK-MEL-28 melanoma cells (results not shown). This is consistent with findings from other studies, where it has been reported that IFN-mediated induction of apoptosis in IFN-sensitive melanoma cell lines occurs much later, by about 48 h of IFN-␤ treatment. (6, 29) Furthermore, our assays for cytotoxicity, based on assaying reporter enzyme levels of cell supernatants, showed that IFN-␤ treatment (for up to 48 h) did not significantly alter the release of luciferase activity (Fig. 3) . Thus, the experimental results from PI staining and supernatant activity assays, when considered together, rule out the possibility that the observed IFN-␤-mediated changes in luciferase activity were caused by compromised cell membrane permeabilization or associated cytotoxic effects of IFN.
The type I IFN-mediated reduction in levels of luciferase activity were also unlikely to be mediated by effects of IFN at the transcriptional level. With no difference in luciferase transcript levels detected between IFN-treated and untreated cells (Fig.  4C,D) , it was concluded that type I IFN-mediated reduction in levels of luciferase activity was most probably mediated by events occurring at the posttranscriptional level. In addition, the inhibition of luciferase activity was unlikely to be the result of differences in the promoters controlling the reporter genes used in this study. Thus, the firefly luciferase and GFP reporter genes, both under the control of the EF-1␣ promoter, both were not inhibited by IFN.
Regulation of protein synthesis is one mechanism that could explain the observed IFN-mediated inhibition of luciferase activity. The effects of IFN treatment on gene expression include downregulation of genes associated with protein synthesis. (28) At the posttranscriptional level, it was reported by Guo et al. (15) that expression of the ISG P56 by IFN-␤ causes inhibition of overall cellular protein synthesis through inhibition of eukaryotic initiation factor 3 (eIF3) function in cells. In addition, their study revealed that cotransfection of cells with a P56 expression vector and a luciferase reporter construct caused inhibition of luciferase protein synthesis. (15) Our study provides evidence for the inhibitory action of IFN-␣ and IFN-␤ on the levels of both firefly and Renilla luciferase reporter activity expressed in transfected cells. As type I IFN-mediated reduction in luciferase activity required an incubation time greater than 8 h, it follows that suppression of the transfected reporter gene expression may well be mediated through the de novo synthesis of an ISG-encoded protein intermediate, such as P56. Our results are also in agreement with the proposal that type I IFN acts at the level of luciferase protein synthesis or turnover. Further studies will be required to determine the precise mechanism of the type I IFN-mediated reduction in luciferase activity expressed in transfected cells and whether the effect is mediated by P56 expression or other IFN-regulated activity affecting protein synthesis (for review, see ref. 14) .
A further complication with the use of dual-luciferase reporter assays was revealed when the effects of increasing the amounts of reporter DNA transfected were examined in both the 96-well and 24 ϫ 2 ml-well format (Figs. 5 and 6 ). Thus, an inhibitory effect was obtained when higher quantities (Ͼ50-100 ng) of reporter DNA were used to transfect cells in dose-response analyses, whereby levels of luciferase activity expressed became significantly reduced. This inhibition associated with the use of excessive amounts of reporter vectors was independent of the type of promoter or luciferase reporter gene expressed, whether Renilla or firefly. A possible explanation for this inhibition could be that transfection with increasing amounts of plasmid DNA causes autogenous expression of IFNs. For example, CaPO 4 DNA precipitates were shown to induce IFN production in transfected cells, (30) and activation of toll-like receptors (TLRs) by double-stranded vector DNA could induce IFN production. (31) In addition, liposomal transfection reagents themselves have been reported to induce IFN production. (32) As we have highlighted in the present study, the IFN produced by transfecting cells could then lead to inhibition in expression of luciferase activity, although further studies would be required to examine this possibility.
With respect to sensitivity of detection and responsiveness of genes to type I IFNs, there is increasing growth in the wealth of array data investigating the role of IFNs in gene regulation. Hence, an increasing amount of focus has been placed on IFN signaling and the investigation of IFN target genes in a variety of cell models. As many of the genes identified in this way show small but biologically significant (ϳ2-fold) differences in gene expression (compared with untreated cells), understanding the broad effects of IFNs on selective posttranslational processing is essential to understanding how gene expression data apply to gene function in specific cell systems, such as cancer biology, where only small differences in expression can have considerable effects on cell behavior. Thus, understanding how to apply reporter gene assays in the context of low levels of response becomes highly significant when validating existing cell signaling pathways and their relevance to pathology. In our study, the levels of IFN-mediated induction of the ISG15-luc reporter in the assay were very significant at ϳ20-fold (Fig.  4A,B) , and, therefore, the inhibitory effects of using 1 g DNA in this dual-reporter assay was not found to affect the outcome. At these levels of induction, the combined inhibitory effect of DNA and IFN actually would cause an underestimation of the fold response to IFN.
The differences in the extent of type I IFN affecting the three different reporter genes indicate that IFN-mediated regulation occurred by a selective rather than by a general mechanism, whereby total cellular protein synthesis was inhibited. In this event, translational regulation by type I IFN would be occur-ring in a targeted mRNA-specific manner (for review, see ref. 33 ). Thus, the present model system could form a useful basis for further analysis of the effects of type I IFNs on the selective transcription/translation coupling of the ISGs.
In summary, our study raises a number of limitations and complications associated with the use of dual-luciferase reporter gene systems and the analysis of genetic regulation of type I IFN-sensitive genes. The evidence supports a direct inhibitory effect of type I IFNs on the expression of both firefly luciferase and Renilla luciferase activity in studies where these transfection reporter assay systems are employed. Caution must be applied when interpreting data from studies of IFN-responsive gene regulation where luciferase reporter systems are used. Therefore, based on the information provided here, it should be possible to design reporter assays providing for greater accuracy of results in situations where use of cytokines or normalization of the data is important.
